Literature DB >> 15181488

Prognostic implications of myoclonic jerk in children with enterovirus infection.

Hsiao-Kuo Lu1, Tzou-Yien Lin, Shao-Hsuan Hsia, Cheng-Hsun Chiu, Yhu-Chering Huang, Kuo-Chien Tsao, Luan-Yin Chang.   

Abstract

To determine the prognostic value of myoclonic jerk in children with enterovirus 71 (EV71) infection, a retrospective study was conducted on 665 enterovirus culture-confirmed patients admitted to Chang Gung Children's Hospital from January 2000 to September 2001. The mean age was 35.0 months +/- 32.2 months, ranging from 1 day to 15 years and 416 (62.6%) of them were male. Among these patients, 140 (21.1%) had EV71 isolated, and 150 (22.6%) had myoclonic jerk. Fifty one percent (72/140) of EV71 cases and only 15% (78/525) of non-EV71 cases had myoclonic jerk (p<0.001). The age of enterovirus patients with myoclonic jerk was younger than that of patients without myoclonic jerk (23.2 +/- 17.6 vs 38.4 +/- 34.6 months, p=0.005). The hospitalization and fever durations were significantly longer in the EV71 group than in the non-EV71 group (8.3 +/- 13 vs 4.2 +/- 2.7 days, p<0.001; 5.9 +/- 4.8 vs 4.2 +/- 3.0 days, p=0.009, respectively). Patients with myoclonic jerk also had higher percentages of severe illness, and neurologic sequelae (20% and 9%, respectively) than those without myoclonic jerk (5% and 1%, respectively) [p<0.001]. The positive predictive values of myoclonic jerk for EV71 infection, severe cases, and neurologic sequelae were 0.48, 0.20, and 0.09, respectively; the negative predictive values for severe cases and neurologic sequelae were 0.95 and 0.99, respectively. This study demonstrated that myoclonic jerk and EV71 infection are both independently associated with more severe disease and higher incidence of neurologic sequelae.

Entities:  

Mesh:

Year:  2004        PMID: 15181488

Source DB:  PubMed          Journal:  J Microbiol Immunol Infect        ISSN: 1684-1182            Impact factor:   4.399


  10 in total

1.  Enterovirus infections in Singaporean children: an assessment of neurological manifestations and clinical outcomes.

Authors:  Wen Yi Thong; Audrey Han; S J Furene Wang; Jeremy Lin; Mas Suhaila Isa; Evelyn Siew Chuan Koay; Stacey Kiat-Hong Tay
Journal:  Singapore Med J       Date:  2016-06-01       Impact factor: 1.858

2.  Clinical characteristics of hand, foot and mouth disease in Daklak Province, Vietnam and associated factors of severe cases.

Authors:  Hau Van Pham; Tuan N A Hoang; Hao T Duong; Lan T Phan; Uyen T N Phan; Nguyen X Ho; Cuong Q Hoang
Journal:  Virusdisease       Date:  2017-09-20

3.  Workshop on use of intravenous immunoglobulin in hand, foot and mouth disease in Southeast Asia.

Authors:  Sokkosal Chea; Yi-Bing Cheng; Kulkanya Chokephaibulkit; Tawee Chotpitayasunondh; H Rogier van Doorn; Zen Hafy; Surinda Kawichai; Ching-Chuan Liu; Nguyen Tran Nam; Mong How Ooi; Marcel Wolbers; Mei Zeng
Journal:  Emerg Infect Dis       Date:  2015-01       Impact factor: 6.883

4.  Neurologic Manifestations of Enterovirus 71 Infection in Korea.

Authors:  Kyung Yeon Lee; Myoung Sook Lee; Dong Bin Kim
Journal:  J Korean Med Sci       Date:  2016-02-22       Impact factor: 2.153

5.  Severity and burden of hand, foot and mouth disease in Asia: a modelling study.

Authors:  Wee Ming Koh; Hishamuddin Badaruddin; Hanh La; Mark I-Cheng Chen; Alex R Cook
Journal:  BMJ Glob Health       Date:  2018-01-26

Review 6.  Enterovirus-Associated Hand-Foot and Mouth Disease and Neurological Complications in Japan and the Rest of the World.

Authors:  Gabriel Gonzalez; Michael J Carr; Masaaki Kobayashi; Nozomu Hanaoka; Tsuguto Fujimoto
Journal:  Int J Mol Sci       Date:  2019-10-20       Impact factor: 5.923

Review 7.  Secondary hypogonadism following hand, foot, and mouth disease in an adult: a case report and review of literature.

Authors:  Zhaoying Chen; Chen Jiang; Xiaoyu Cheng; Lidan Ma; Ying Xin; Tian Liu; Ruixia Sun
Journal:  BMC Infect Dis       Date:  2022-01-15       Impact factor: 3.090

8.  Enterovirus-A71 Rhombencephalitis Outbreak in Catalonia: Characteristics, Management and Outcome.

Authors:  Núria Wörner; Rocío Rodrigo-García; Andrés Antón; Ester Castellarnau; Ignacio Delgado; Èlida Vazquez; Sebastià González; Lluís Mayol; Maria Méndez; Eduard Solé; Jaume Rosal; Cristina Andrés; Alejandro Casquero; Esther Lera; Mónica Sancosmed; Magda Campins; Tomàs Pumarola; Carlos Rodrigo
Journal:  Pediatr Infect Dis J       Date:  2021-07-01       Impact factor: 2.129

9.  Neurological complications and risk factors of cardiopulmonary failure of EV-A71-related hand, foot and mouth disease.

Authors:  Lili Long; Lin Xu; Zhenghui Xiao; Shixiong Hu; Ruping Luo; Hua Wang; Xiulan Lu; Zhiyue Xu; Xu Yao; Luo Zhou; Hongyu Long; Jiaoe Gong; Yanmin Song; Li Zhao; Kaiwei Luo; Mengqi Zhang; Li Feng; Liming Yang; Xiaoqi Sheng; Xuegong Fan; Bo Xiao
Journal:  Sci Rep       Date:  2016-03-22       Impact factor: 4.379

Review 10.  Outcomes following severe hand foot and mouth disease: A systematic review and meta-analysis.

Authors:  Eben Jones; Timesh D Pillay; Fengfeng Liu; Li Luo; Juan Carlos Bazo-Alvarez; Chen Yuan; Shanlu Zhao; Qi Chen; Yu Li; Qiaohong Liao; Hongjie Yu; H Rogier van Doorn; Saraswathy Sabanathan
Journal:  Eur J Paediatr Neurol       Date:  2018-04-20       Impact factor: 3.140

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.